Why the study?
Does long-term antibiotic therapy benefit patients with surgery-indicated infective endocarditis who cannot undergo surgery?
Does long-term antibiotic therapy benefit patients with surgery-indicated infective endocarditis who cannot undergo surgery?
Answers are grounded in this paper and cite their sources.
Long-term antibiotic therapy may be considered as a management strategy for patients with infective endocarditis who have an indication for surgery but are unable to undergo it.
The present study results suggest that a LTAT strategy, including LOSAT, might be considered for patients with IE that cannot undergo an indicated surgery. After hospitalization, they should be followed by a multidisciplinary endocarditis team.
No takes yet. Share an insight, caveat, or question.
Vallejo et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: